David Mahvi to Salvage Therapy
This is a "connection" page, showing publications David Mahvi has written about Salvage Therapy.
Connection Strength
0.062
-
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma. Cancer Immunol Immunother. 2006 Jul; 55(7):761-74.
Score: 0.062